Search

everythinglearnresearchcommunity

for

Search:↓

Higher levels of certain proteins in the blood are linked to more severe patchy alopecia areata.

Hair loss in women not always linked to increased oil production; other factors may be involved.

Alopecia areata patients have higher levels of IL-6 and TNF-α.

Alopecia areata patients have higher IFN-γ and low vitamin D3 levels.

Thyroid tests may not be needed for all vitiligo and alopecia areata patients unless thyroid disease symptoms appear.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

Higher prolactin levels in women may be linked to pilonidal sinus disease.

Low ferritin levels can indicate iron deficiency as a cause of hair loss.

Adolescent females with PCOS have higher serum cystatin C levels, indicating potential metabolic and cardiovascular issues.

High levels of Anti-Müllerian Hormone (AMH) in the blood can strongly predict Polycystic Ovarian Syndrome (PCOS) and related issues in women of reproductive age.

Surgeons' testosterone levels significantly increase during major head and neck cancer surgeries.

Women with hyperandrogenism have higher androgen levels and lower SHBG, which may contribute to conditions like excessive hair growth and early puberty.

Higher miR-34a levels and the A variant of the MIR-34A gene are linked to increased risk and severity of alopecia areata.

Higher levels of IL-1R1 and hsa-miR-19b-3p may help diagnose and predict alopecia areata severity.

Micronutrient deficiencies are common in hypothyroidism-related hair loss, so monitoring these nutrients may help manage hair health.

Patients with alopecia areata have higher levels of certain immune markers, suggesting new treatment targets.

Changes in hair follicle structure may help diagnose and monitor alopecia.

High androgen levels can cause hirsutism and increase inflammation.

People with androgenetic alopecia have different lipid levels in their blood, which vary between men and women, and may be linked to a higher risk of metabolic syndrome.

Higher PSA levels are linked to more hirsutism in women with PCOS.

Higher Interleukin 17A levels may indicate more severe alopecia areata.

Prolactin levels are higher in women with hirsutism but don't relate to its severity.

Higher FABP4 levels may help diagnose androgenetic alopecia early.

Young men with early hair loss and high SAA3 levels are at higher risk for heart disease.

Sensitive scalp has higher pH, more redness, abnormal sebum, and altered bacterial makeup.

Oral testosterone therapy raises heart risk more than other methods.

Higher levels of IL-17A and IL-2 are linked to alopecia areata.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

A woman's male-like symptoms and high testosterone were due to ovarian hilus-cell hyperplasia, which improved after surgery.